Biocompatible evaluation of barium titanate foamed ceramic structures for orthopedic applications.

The potential of barium titanate (BT) to be electrically active makes it a material of interest in regenerative medicine. To enhance the understanding of this material for orthopedic applications, the in vitro biocompatibility of porous BT fabricated using a direct foaming technique was investigated. Characterization of the resultant foams yielded an overall porosity between 50 and 70% with average pore size in excess of 30 µm in diameter. A mouse osteoblast (7F2) cell line was cultured with the BT to determine the extent of the foams' toxicity using a LDH assay. After 72 h, BT foams showed a comparable cytotoxicity of 6.4 ± 0.8% to the 8.4 ± 1.5% of porous 45S5 Bioglass®. The in vitro inflammatory response elicited from porous BT was measured as a function of tumor necrosis factor alpha (TNF-α) secreted from a human monocytic leukemia cell line (THP-1). Results indicate that the BT foams do not cause a significant inflammatory response, eliciting a 9.4 ± 1.3 pg of TNF-α per mL of media compared with 20.2 ± 2.3 pg/mL from untreated cells. These results indicate that porous BT does not exhibit short term cytotoxicity and has potential for orthopedic tissue engineering applications.

[1]  H. Kornfeld,et al.  THP-1 Cell Apoptosis in Response to Mycobacterial Infection , 2003, Infection and Immunity.

[2]  Sangwon Chung,et al.  Design concepts and strategies for tissue engineering scaffolds , 2011, Biotechnology and applied biochemistry.

[3]  S. Adams,et al.  Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[4]  B D Boyan,et al.  Role of material surfaces in regulating bone and cartilage cell response. , 1996, Biomaterials.

[5]  S. Hollister.  Porous scaffold design for tissue engineering , 2005, Nature materials.

[6]  E. Traversa,et al.  Synthesis and Characterization of BaTiO3‐Based Foams with a Controlled Microstructure , 2009 .

[7]  Tabatabaei Qomi,et al.  The Design of Scaffolds for Use in Tissue Engineering , 2014 .

[8]  A S Brydone,et al.  Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering , 2010, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[9]  A F von Recum,et al.  Piezoelectric ceramic implants: in vivo results. , 1981, Journal of biomedical materials research.

[10]  Xing‐dong Zhang,et al.  Promotion of osteogenesis by a piezoelectric biological ceramic , 1997 .

[11]  M L Moss,et al.  The functional matrix hypothesis revisited. 1. The role of mechanotransduction. , 1997, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[12]  P. D. Kraan,et al.  Bone morphogenetic proteins and articular cartilage: To serve and protect or a wolf in sheep clothing's? , 2010 .

[13]  X Zhang,et al.  Promotion of osteogenesis by a piezoelectric biological ceramic. , 1997, Biomaterials.

[14]  S. Licoccia,et al.  Foaming of filled polyurethanes for fabrication of porous anode supports for intermediate temperature-solid oxide fuel cells , 2006 .

[15]  Jeffrey A. Hubbell,et al.  Biomaterials in Tissue Engineering , 1995, Bio/Technology.

[16]  E. W. Washburn.  The Dynamics of Capillary Flow , 1921 .

[17]  J. Wataha,et al.  Human peripheral blood monocytes versus THP-1 monocytes for in vitro biocompatibility testing of dental material components. , 2002, Journal of oral rehabilitation.

[18]  U Kneser,et al.  Tissue engineering of bone: the reconstructive surgeon's point of view , 2006, Journal of cellular and molecular medicine.

[19]  K. Tanner.  Bioactive composites for bone tissue engineering , 2010, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[20]  K. Leong,et al.  The design of scaffolds for use in tissue engineering. Part I. Traditional factors. , 2001, Tissue engineering.

[21]  W. B. van den Berg,et al.  Bone morphogenetic proteins and articular cartilage: To serve and protect or a wolf in sheep clothing's? , 2010, Osteoarthritis and cartilage.

[22]  M. Fathi,et al.  Synthesis, Characterization and Bioactivity Evaluation of Porous Barium Titanate with Nanostructured Hydroxyapatite Coating for Biomedical Application , 2012 .

[23]  M. Harmsen,et al.  Cellular and molecular dynamics in the foreign body reaction. , 2006, Tissue engineering.

[24]  Lonnie D Shea,et al.  Tissue engineering tools for modulation of the immune response. , 2011, BioTechniques.

[25]  O. Terasaki,et al.  High-performance mesoporous bioceramics mimicking bone mineralization , 2008 .

[26]  N. Vilaboa,et al.  Differential inflammatory macrophage response to rutile and titanium particles. , 2006, Biomaterials.

[27]  Andrew A. Marino,et al.  Origin of the piezoelectric effect in bone , 2005, Calcified Tissue Research.

[28]  Molly M. Stevens,et al.  Biomaterials for bone tissue engineering , 2008 .

[29]  Christopher R Bowen,et al.  An in vitro study of electrically active hydroxyapatite-barium titanate ceramics using Saos-2 cells , 2009, Journal of materials science. Materials in medicine.

[30]  W. R. Moore,et al.  Synthetic bone graft substitutes , 2001, ANZ journal of surgery.

[31]  C. Whitfield,et al.  Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.

[32]  I. G. Turner,et al.  Electrically Active Bioceramics: A Review of Interfacial Responses , 2010, Annals of Biomedical Engineering.

[33]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[34]  André R. Studart,et al.  Processing Routes to Macroporous Ceramics: A Review , 2006 .

[35]  D. O’Toole,et al.  Activated protein C inhibits lipopolysaccharide‐induced nuclear translocation of nuclear factor κB (NF‐κB) and tumour necrosis factor α (TNF‐α) production in the THP‐1 monocytic cell line , 2000, British journal of haematology.

[36]  J. Klawitter,et al.  Application of porous ceramics for the attachment of load bearing internal orthopedic applications , 1971 .

[37]  S. D. Nunn,et al.  Development of Low‐Toxicity Gelcasting Systems , 2005 .

[38]  R. Zellweger,et al.  BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONS , 2007, ANZ journal of surgery.

[39]  Jian Yang,et al.  Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. , 2007, Journal of biomedical materials research. Part A.

[40]  Fergal J O'Brien,et al.  The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. , 2010, Biomaterials.

[41]  Miho Nakamura,et al.  Enhanced bone ingrowth into hydroxyapatite with interconnected pores by Electrical Polarization. , 2006, Biomaterials.

[42]  Sónia Fraga,et al.  Influence of the surface coating on the cytotoxicity, genotoxicity and uptake of gold nanoparticles in human HepG2 cells , 2013, Journal of applied toxicology : JAT.

[43]  Rui L Reis,et al.  Bone tissue engineering: state of the art and future trends. , 2004, Macromolecular bioscience.

[44]  D. Kaplan,et al.  Porosity of 3D biomaterial scaffolds and osteogenesis. , 2005, Biomaterials.

[45]  Larry L. Hench,et al.  Regeneration of trabecular bone using porous ceramics , 2003 .

[46]  V. Fadok,et al.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.